TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
RÉGINA, A., ROMERO, I.A., GREENWOOD, J., ADAMSON, P., BOURRE, J.M., COURAUD, P.O.,
ROUX, F., 1999. Dexamethasone regulation of P-glycoprotein activity in an immortalized rat
brain endothelial cell line, GPNT. J. Neurochem. 73: 1954-63.
REINHARDT, C.A., GLOOR, S.M., 1997. Co-culture blood-brain barrier models and their use for
pharmatoxicological screening. Toxicol In Vitro. 11: 513-518.
REMY, S., BECK, H., 2006. Molecular and cellular mechanisms of pharmacoresistance in epilepsy.
Brain 129: 18-35.
REMY, S., GABRIEL, S., URBAN, B.W., DIETRICH, D., LEHMANN, T.N., ELGER, C.E.,
HEINEMANN, U., BECK, H., 2003. A novel mechanism underlying drug resistance in chronic
epilepsy. Ann. Neurol. 53: 469-479.
RENES, J., DE VRIES, E.G., NIENHUIS, E.F., JANSEN, P.L., MULLER, M., 1999. ATP- and
glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance
protein MRP1. Br J Pharmacol. 126: 681-688.
REUSS, B., DONO, R., UNSICKER K., 2003. Functions of fibroblast growth factor (FGF)-2 and FGF-5
in astroglial differentiation and blood-brain barrier permeability: Evidence from mouse mutants.
J Neurosci. 23: 6404-6412.
RIZZI, M., CACCIA, S., GUISO, G., RICHICHI, C., GORTER, J.A., ARONICA, E., ALIPRANDI, M.,
BAGNATI, R., FANELLI, R., D'INCALCI, M., SAMANIN, R., VEZZANI, A., 2002. Limbic
seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance.
J. Neurosci. 22: 5833-5839.
ROBEY, R.W., HONJO, Y., VAN DE, L.A., MIYAKE, K., REGIS, J.T., LITMAN, T., BATES, S.E., 2001.
A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).
Biochim.Biophys.Acta 1512: 171-182.
ROBEY, R.W., LAZAROWSKI, A., BATES, S.E., 2008b. Pgp- a clinical target in drug-refractory
epilepsy? Mol. Pharmacol. 73: 1343-1346.
ROBEY, R.W., SHUKLA, S., FINLEY, E.M., OLDHAM, R.K., BARNETT, D., AMBUDKAR, S.V., FOJO,
T., BATES, S.E., 2008a. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistanceassociated
protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-
1(IST). Biochem Pharmacol. 75: 1302-12.
ROBEY, R. W., STEADMAN, K. , POLGAR, O., MORISAKI, K., BLAYNEY, M., MISTRY, P., BATES,
S.E., 2004. Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res.
64: 1242-1246.
ROBEY, R.W., TO, K.K.K, POLGAR, O., DOHSE, M., FETSCH, P., DEAN, M., BATES, S.E., 2009.
ABCG2: a perspective. Adv Drug Deliv Rev. 61: 3-13.
ROGAWSKI, M.A., LÖSCHER, W., 2004. The neurobiology of antiepileptic drugs for the treatment of
nonepileptic conditions. Nat. Med. 10: 685-692.
ROUX, F., COURAUD, P.O., 2005. Rat Brain Endothelial Cell Lines for the Study of Blood–Brain
Barrier Permeability and Transport Functions. Cell. Mol. Neurobiol. 25: 41-58.
ROUX, F., DURIEU-TRAUTMANN, O., CHAVEROT, N., CLAIRE, M., MAILLY, P., BOURRE, J.M.,
STROSBERG, A.D., COURAUD, P.O., 1994. Regulation of gamma-glutamyl transpeptidase
198